Clarivate PLC $CLVT Stake Lifted by LSV Asset Management

LSV Asset Management boosted its holdings in shares of Clarivate PLC (NYSE:CLVT) by 25.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,647,900 shares of the company’s stock after purchasing an additional 540,400 shares during the period. LSV Asset Management owned approximately 0.40% of Clarivate worth $8,844,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CLVT. Cetera Investment Advisers lifted its position in shares of Clarivate by 11.2% in the 2nd quarter. Cetera Investment Advisers now owns 26,034 shares of the company’s stock valued at $112,000 after acquiring an additional 2,617 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Clarivate by 0.9% in the 2nd quarter. California State Teachers Retirement System now owns 303,147 shares of the company’s stock valued at $1,304,000 after acquiring an additional 2,788 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Clarivate by 3.9% in the 3rd quarter. Envestnet Asset Management Inc. now owns 77,275 shares of the company’s stock valued at $296,000 after acquiring an additional 2,884 shares in the last quarter. IFP Advisors Inc lifted its position in shares of Clarivate by 8.1% in the 3rd quarter. IFP Advisors Inc now owns 41,426 shares of the company’s stock valued at $170,000 after acquiring an additional 3,117 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its position in shares of Clarivate by 4.3% in the 2nd quarter. Hsbc Holdings PLC now owns 116,648 shares of the company’s stock valued at $500,000 after acquiring an additional 4,792 shares in the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.

Clarivate Stock Performance

Shares of CLVT opened at $2.46 on Tuesday. Clarivate PLC has a 12 month low of $1.66 and a 12 month high of $4.77. The company’s fifty day moving average is $2.52 and its 200-day moving average is $2.83. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.89. The firm has a market cap of $1.57 billion, a price-to-earnings ratio of -11.69 and a beta of 1.41.

Clarivate (NYSE:CLVT) last posted its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The business had revenue of $585.50 million for the quarter, compared to analyst estimates of $569.50 million. During the same period last year, the business posted $0.14 EPS. Clarivate’s revenue was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Equities analysts expect that Clarivate PLC will post 0.65 EPS for the current fiscal year.

Analyst Ratings Changes

CLVT has been the subject of several research analyst reports. Barclays reduced their price target on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a research report on Wednesday, February 25th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Citigroup dropped their price objective on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a research note on Wednesday, March 4th. Finally, Royal Bank Of Canada dropped their price objective on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a research note on Wednesday, February 25th. Five equities research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $3.22.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.